Merck Loosens 340B Contract Pharmacy Restrictions in Two States as Louisiana Law Takes Effect

Merck
Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.
Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana’s New 340B Contract Pharmacy Law Goes Into Effect Today; PhRMA Sues and Teva Suspends its Restrictions in the State

PhRMA v. Landry
Brand drug trade group PhRMA is suing Louisiana over its law protecting 340B contract pharmacy arrangements.
Today is the first day of Louisiana’s new law protecting 340B program contract pharmacy arrangements and there have already been [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House E&C GOP Leaders’ Draft Bill Would Exempt Sterile Generic Injectables from 340B Pricing Requirements

House Energy & Commerce Committee's draft bill.
GOP leaders on the House Energy & Commerce Committee released a draft bill to address drug shortages that includes a provision that would exempt certain drug products from 340B pricing requirements.
Republican leaders of the U.S. House Energy and Commerce (E&C) Committee released a draft bill late last week that would [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

Senate Finance Committee PBM reform bill markup.
The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.
The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Panel Seems to Be on Track To Vote Tomorrow on Bill With Language that 340B Providers Oppose

Ron Wyden and Mike Crapo
Sens. Ron Wyden (left) and Mike Crapo's final revised PBM reform bill appears to retain language that 340B provider groups oppose.
The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RWC-340B Backs Senate Bill That Would Let Ryan White Clinics Cover HIV Prevention Drugs and Services

PrEP tablet
New U.S. Senate legislation would let Ryan White clinics voluntarily use federal grants for HIV prevention medications and associated services.
Ryan White Clinics for 340B Access (RWC-340B) last week praised a new bill in the U.S. Senate that would let [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B May Cause Providers to Buy More Expensive HIV Prevention Drugs, Conservative Policy Group Says

American Action Forum
The American Action Forum says in a new paper that 340B incentivizes providers to favor more expensive HIV medications, "raising costs for the rest of the health care system."
The 340B drug pricing program may incentivize hospitals and other covered entities to buy expensive preventative HIV medications over low-cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

Johnson & Johnson and Astellas
Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Panel Could Mark Up PBM Bill Next Week With Spread Pricing Language That 340B Providers Oppose

Senate Finance Committee
A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.
The U.S. Senate Finance Committee could mark up a pharmacy benefit manager reform bill next week with Medicaid managed care [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Chamber of Commerce Asks Court to Pause Medicare Drug Price Negotiations

U.S. Chamber of Commerce
The U.S. Chamber of Commerce asked a federal district court last week for a preliminary injunction against Medicare drug price negotiation.
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer